These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 18715798

  • 1. Complement activation cascade and its regulation: relevance for the response of solid tumors to photodynamic therapy.
    Korbelik M, Cecic I.
    J Photochem Photobiol B; 2008 Oct 16; 93(1):53-9. PubMed ID: 18715798
    [Abstract] [Full Text] [Related]

  • 2. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT.
    Cancer Res; 2003 Nov 15; 63(22):7584-90. PubMed ID: 14633671
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors.
    Korbelik M, Sun J, Cecic I, Serrano K.
    Photochem Photobiol Sci; 2004 Aug 15; 3(8):812-6. PubMed ID: 15295639
    [Abstract] [Full Text] [Related]

  • 4. Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy.
    Cecic I, Stott B, Korbelik M.
    Int Immunopharmacol; 2006 Aug 15; 6(8):1259-66. PubMed ID: 16782538
    [Abstract] [Full Text] [Related]

  • 5. The impact of complement activation on tumor oxygenation during photodynamic therapy.
    Cecic I, Minchinton AI, Korbelik M.
    Photochem Photobiol; 2007 Aug 15; 83(5):1049-55. PubMed ID: 17880499
    [Abstract] [Full Text] [Related]

  • 6. Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis.
    Kaminski HJ, Li Z, Richmonds C, Lin F, Medof ME.
    Exp Neurol; 2004 Oct 15; 189(2):333-42. PubMed ID: 15380483
    [Abstract] [Full Text] [Related]

  • 7. Expression of complement and pentraxin proteins in acute phase response elicited by tumor photodynamic therapy: the engagement of adrenal hormones.
    Merchant S, Huang N, Korbelik M.
    Int Immunopharmacol; 2010 Dec 15; 10(12):1595-601. PubMed ID: 20933626
    [Abstract] [Full Text] [Related]

  • 8. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response.
    Korbelik M, Sun J, Cecic I.
    Cancer Res; 2005 Feb 01; 65(3):1018-26. PubMed ID: 15705903
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy.
    Cecic I, Serrano K, Gyongyossy-Issa M, Korbelik M.
    Cancer Lett; 2005 Jul 28; 225(2):215-23. PubMed ID: 15978326
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systemic toxicity in mice induced by localized porphyrin photodynamic therapy.
    Ferrario A, Gomer CJ.
    Cancer Res; 1990 Feb 01; 50(3):539-43. PubMed ID: 2137023
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor.
    Krosl G, Korbelik M, Krosl J, Dougherty GJ.
    Cancer Res; 1996 Jul 15; 56(14):3281-6. PubMed ID: 8764122
    [Abstract] [Full Text] [Related]

  • 14. Anti-tumor effect of PDT using Photofrin in a mouse angiosarcoma model.
    Jin I, Yuji M, Yoshinori N, Makoto K, Mikio M.
    Arch Dermatol Res; 2008 Apr 15; 300(4):161-6. PubMed ID: 18080130
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
    Ravindranath NM, Shuler C.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb 15; 103(2):231-9. PubMed ID: 17234541
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Co-expression of the complement regulatory proteins human DAF and CD59 with an IRES-mediated dicistronic mammalian vector enhances their cell protective effects.
    Xu L, Shao H, Wu W, Cao Z, Zhao Z, Liu H, Jiang D, Mao X, Li W.
    Int J Mol Med; 2005 Sep 15; 16(3):409-14. PubMed ID: 16077947
    [Abstract] [Full Text] [Related]

  • 19. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K, Usuda J, Ichinose S, Ishizumi T, Hirata T, Inoue T, Maehara S, Imai K, Kubota M, Tsunoda Y, Yamada M, Tsutsui H, Yamada K, Kuroiwa Y, Furukawa K, Okunaka T, Kato H.
    Int J Oncol; 2008 Feb 15; 32(2):397-403. PubMed ID: 18202762
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.